Local anesthetic combination

8 marketed 3 in Phase 3

This page covers all Local anesthetic combination drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Voltage-gated sodium channels; NMDA receptor, Voltage-gated sodium channels, Voltage-gated sodium channels (bupivacaine); alpha-1 adrenergic receptors (epinephrine); glucocorticoid receptor (dexamethasone).

Targets

Voltage-gated sodium channels; NMDA receptor · Voltage-gated sodium channels · Voltage-gated sodium channels (bupivacaine); alpha-1 adrenergic receptors (epinephrine); glucocorticoid receptor (dexamethasone) · Voltage-gated sodium channels (bupivacaine); acetylcholinesterase (neostigmine)

Marketed (8)

Phase 3 pipeline (3)